A validated liquid chromatography‐tandem mass spectroscopy method for the quantification of tolinapant in human plasma
Abstract Tolinapant (ASTX660), a pan‐selective inhibitor of apoptosis protein antagonist with dual cIAP/XIAP activity, was identified as a clinical candidate in preclinical efficacy, pharmacokinetic and safety studies. In order to assess tolinapant in first‐in‐human Phase I/II clinical trials, a val...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley-VCH
2022-06-01
|
| Edice: | Analytical Science Advances |
| On-line přístup: | https://doi.org/10.1002/ansa.202200009 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|